Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study

• Principais autores: Jeffrey R. Wagner (Autor), Jesse K. Fitzpatrick (Autor), Jingrong Yang (Autor), Sue Hee Sung (Autor), Amanda R. Allen (Autor), Sephy Philip (Autor), Craig Granowitz (Autor), David Abrahamson (Autor), Andrew P. Ambrosy (Autor), Alan S. Go (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2022-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: Patients with risk factors for or established atherosclerotic cardiovascular disease (ASCVD) remain at high risk for subsequent ischemic events despite statin therapy. Triglyceride (TG) levels may contribute to residual ASCVD risk, and the performance of global risk assessment calculators...